Cargando…
MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
BACKGROUND: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. MicroRNAs (miRNAs) are involved in essential biological activities, in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522974/ https://www.ncbi.nlm.nih.gov/pubmed/26238857 http://dx.doi.org/10.1186/s12967-015-0592-z |
_version_ | 1782384019524026368 |
---|---|
author | Zheng, Lin Zhang, Yuqin Liu, Yan Zhou, Min Lu, Yanxia Yuan, Li Zhang, Chao Hong, Min Wang, Shuang Li, Xuenong |
author_facet | Zheng, Lin Zhang, Yuqin Liu, Yan Zhou, Min Lu, Yanxia Yuan, Li Zhang, Chao Hong, Min Wang, Shuang Li, Xuenong |
author_sort | Zheng, Lin |
collection | PubMed |
description | BACKGROUND: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. MicroRNAs (miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. Several research studies have indicated that miRNA played an important role in sensitizing cells to ionizing radiation (IR). MiR-106b, a member of the miR-106b-25 cluster, is frequently dysregulated in many human cancers, including CRC. However, the function of miR-106b in radioresistance is currently poorly understood. METHODS: A series of in vitro and in vivo studies were performed to investigate the roles of miR-106b on cell radioresistance in CRC. RESULTS: We found overexpression of miR-106b could induce resistance to IR in vitro and in vivo in SW620 cells. Correspondingly, knocking down miR-106b in SW480 yielded the opposite effect. In addition, overexpression of miR-106b could enhance the tumour-initiating cell capacity without or with IR condition, such as the colony sphere formation capacity and the upregulation of stemness-related genes (CD133, Sox2). We further identified PTEN and p21 as novel direct targets of miR-106b by using target prediction algorithms and a luciferase assay. Overexpression of miR-106b reduced the expression of PTEN and p21 and increased the expression of p-AKT, which is a downstream of PTEN. Restoring the expression of PTEN or p21 in stably miR-106b-overexpressed cells could rescue the effect of miR-106b on cell radioresistance. Together, the acquisition of tumour-initiating cell capacity endowed CRC cells with the potential of resistance to irradiation. CONCLUSIONS: These observations illustrated that miR-106b could induce cell radioresistance by directly targeting PTEN and p21, this process was accompanied by tumour-initiating cell capacity enhancement, which is universally confirmed to be associated with radioresistance. Our data suggested that miR-106b at least partly induces cell radioresistance in CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0592-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4522974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45229742015-08-04 MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer Zheng, Lin Zhang, Yuqin Liu, Yan Zhou, Min Lu, Yanxia Yuan, Li Zhang, Chao Hong, Min Wang, Shuang Li, Xuenong J Transl Med Research BACKGROUND: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. MicroRNAs (miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. Several research studies have indicated that miRNA played an important role in sensitizing cells to ionizing radiation (IR). MiR-106b, a member of the miR-106b-25 cluster, is frequently dysregulated in many human cancers, including CRC. However, the function of miR-106b in radioresistance is currently poorly understood. METHODS: A series of in vitro and in vivo studies were performed to investigate the roles of miR-106b on cell radioresistance in CRC. RESULTS: We found overexpression of miR-106b could induce resistance to IR in vitro and in vivo in SW620 cells. Correspondingly, knocking down miR-106b in SW480 yielded the opposite effect. In addition, overexpression of miR-106b could enhance the tumour-initiating cell capacity without or with IR condition, such as the colony sphere formation capacity and the upregulation of stemness-related genes (CD133, Sox2). We further identified PTEN and p21 as novel direct targets of miR-106b by using target prediction algorithms and a luciferase assay. Overexpression of miR-106b reduced the expression of PTEN and p21 and increased the expression of p-AKT, which is a downstream of PTEN. Restoring the expression of PTEN or p21 in stably miR-106b-overexpressed cells could rescue the effect of miR-106b on cell radioresistance. Together, the acquisition of tumour-initiating cell capacity endowed CRC cells with the potential of resistance to irradiation. CONCLUSIONS: These observations illustrated that miR-106b could induce cell radioresistance by directly targeting PTEN and p21, this process was accompanied by tumour-initiating cell capacity enhancement, which is universally confirmed to be associated with radioresistance. Our data suggested that miR-106b at least partly induces cell radioresistance in CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0592-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-04 /pmc/articles/PMC4522974/ /pubmed/26238857 http://dx.doi.org/10.1186/s12967-015-0592-z Text en © Zheng et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zheng, Lin Zhang, Yuqin Liu, Yan Zhou, Min Lu, Yanxia Yuan, Li Zhang, Chao Hong, Min Wang, Shuang Li, Xuenong MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
title | MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
title_full | MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
title_fullStr | MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
title_full_unstemmed | MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
title_short | MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
title_sort | mir-106b induces cell radioresistance via the pten/pi3k/akt pathways and p21 in colorectal cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522974/ https://www.ncbi.nlm.nih.gov/pubmed/26238857 http://dx.doi.org/10.1186/s12967-015-0592-z |
work_keys_str_mv | AT zhenglin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT zhangyuqin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT liuyan mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT zhoumin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT luyanxia mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT yuanli mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT zhangchao mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT hongmin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT wangshuang mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer AT lixuenong mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer |